Ontology highlight
ABSTRACT: Purpose
The current meta-analysis aimed to summarize the available evidence for the efficacy and serious adverse events (AEs) associated with use of metronomic chemotherapy (MCT) in patients with metastatic breast cancer (MBC).Method
Electronic databases (PubMed, EMBASE database, Web of Knowledge, and the Cochrane database) were systematically searched for articles related to the use of MCT in MBC patients. Eligible studies included clinical trials of MBC patients treated with MCT that presented sufficient data related to tumor response, progression-free survival (PFS), overall survival (OS), and grade 3/4 AEs. A meta-analysis was performed using a random effects model.Results
This meta-analysis consists of 22 clinical trials with 1360 patients. The pooled objective
SUBMITTER: Liu Y
PROVIDER: S-EPMC5351982 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature